Invasive Breast Cancer Clinical Trials in Boston, Massachusetts
4 recruitingBoston, Massachusetts
Showing 1–4 of 4 trials
Recruiting
Phase 2
Sacituzumab Govitecan In TNBC
Triple-Negative Breast CancerHER2-negative Breast CancerInvasive Breast Cancer+2 more
Massachusetts General Hospital260 enrolled5 locationsNCT04230109
Recruiting
Not Applicable
CONFIRM: Magnetic Resonance Guided Radiation Therapy
Gastric CancerIn Situ Breast CancerInvasive Breast Cancer+3 more
Brigham and Women's Hospital70 enrolled2 locationsNCT04368702
Recruiting
Phase 2
Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
Invasive Breast CancerStage III Breast CancerStage IIB Breast Cancer+4 more
Jonsson Comprehensive Cancer Center88 enrolled9 locationsNCT04553770
Recruiting
Phase 2
TRUDI: TDXD+Durva in HER2+/Low IBC
Breast CancerInvasive Breast CancerHER2-positive Breast Cancer+2 more
Filipa Lynce, MD63 enrolled3 locationsNCT05795101